Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture

Ophthalmic Genetics

Volumn 23, Issue 3, 2002, Pages 137-156

  Albert, Daniel M ^a   Nickells, Robert W ^a   Gamm, David M ^a   Zimbric, Michele L ^a   Schlamp, Cassandra L ^a   Lindstrom, Mary J ^a   Audo, Isabelle ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Apoptosis; p21; p53; Retinoblastoma; Vitamin D analogs

Indexed keywords

CALCITRIOL; CALCIUM; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; ERGOCALCIFEROL; MESSENGER RNA; PROTEIN P53; TRANSFERASE; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM BLOOD LEVEL; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LIGATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; XENOGRAFT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALCITRIOL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE MODELS, ANIMAL; DNA PRIMERS; ERGOCALCIFEROLS; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MICE; MICE, NUDE; MICE, TRANSGENIC; PORTRAITS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CALCITRIOL; RETINAL NEOPLASMS; RETINOBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS MUSCULUS;

EID: 0036397635     PISSN: 13816810     EISSN: None     Source Type: Journal    
DOI: 10.1076/opge.23.3.137.7883     Document Type: Article

References (50)

1. Jackson Coleman D. RM Ellsworth obituary. In: New York Times. Jan. 5, 1994.
2. Ferris FL, Chew EY. A new era for the treatment of RB. Arch Ophthalmol. 1996;114:1412.
3. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice Jr. JD. Mortality from second tumors among the long-term survivors of RB. J Natl Cancer Inst. 1993;85:1121-1128.
4. Roarty JD, McLean IW, Zimmerman LE. Incidence of second neoplasms in patients with bilateral RB. Ophthalmology. 1988;95:1583-1587.
5. Abramson DH, Frank CM. Second nonocular tumors in survivors of bilateral RB. A possible age effect on radiation-related risk. Ophthalmology. 1998;105:573-580.
6. Gallie BL, Budning A, DeBoer G, Thiessen JJ, Koren G, Verjee Z, Ling V, Chang HS-L. Chemotherapy with focal therapy can cure intraocular RB without radiotherapy. Arch Ophthalmol. 1996;114:1321-1328.
7. Verhoeff R. RB undergoing spontaneous regression: Calcifying agents suggested in treatment of RB. Am J Ophthalmol. 1966;62:573-574.
8. Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu ES, Tralka TS, Wilcox J. Characteristics of an established cell line of RB. J Natl Cancer Inst. 1974;53:347-360.
9. Gallie BL, Albert DM, Wong JJ, Buyukmihci N, Puliafito CA. Heterotransplantation of RB into the athymic 'nude' mouse. Invest Ophthalmol Vis Sci. 1977;16:256-299
10. Windle JJ, Albert DM, O'Brien JM, Marcus DM, Disteche CM, Bernards R, Mellon PL. RB in transgenic mice. Nature. 1990;343:665-669.
11. O'Brien JM, Marcus DM, Bernards R, Carpenter JL, Windle JJ, Mellon P, Albert DM. A transgenic mouse model for RB. Arch Ophthalmol. 1990;108:1145-1151.
12. Koshy KT. Vitamin D: An Update. J Pharm Sci. 1982;71:137-152.
13. 3. J Clin Endocrinol Metab. 1980;50:773-775.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
15. Saulenas A, Cohen S, Key L, Winter C, Albert DM. Vitamin D and RB: The presence of receptors and inhibition of growth in vitro. Arch Ophthalmol. 1988;106:533-535.
16. 3 in athymic mice with Y-79 human RB tumors. Arch Ophthalmol. 1999;117:365-370.
17. 2 in a retinoblastoma xenograft model. Arch Ophthalmol. 2002, in press.
18. Albert DM, Saulenas AM, Cohen SM. Verhoeff's query: Is vitamin D effective against RB? Arch Ophthalmol. 1988;106:536-540.
19. Albert DM, Marcus DM, Gallo JP, O'Brien JM. The antineoplastic effect of vitamin D in transgenic mice with RB. Invest Ophthalmol Vis Sci. 1992;33:2354-2364.
20. 3 analogue in transgenic mice with RB. Arch Ophthalmol. 1996;114:1396-1401.
21. 3 in transgenic mice. Clin Cancer Research. 1998;4:2253-2256.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell deathin situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
23. Quigley HA, Nickells RW, Kerrigan La, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36:774-786.
24. Nork TM, Poulsen G, Millecchia LL, Jantz RG, Nickells RW. p53 regulates apoptosis in human RB. Arch Ophthalmol. 1997;115:213-219.
25. Didenko VV, Hornsby PJ. Presence of double-strand breaks with single-ase 3′ overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol. 1996;135:1369-1376.
26. Reitsma PH, Rothberg PG, Astrin SM, Trial J, Bar-Shavit Z, Hall A, Teitelbaum SL, Kahn AJ. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature. 1983;306:492-494.
27. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): Receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984;98:391-398.
28. Colston RW, Feldman D. Demonstration of a 1,25-dihydroxycholecalciferol cytoplasmic receptor-like binder in mouse kidney. J Clin Endocrinol Metab. 1979;49:798-800.
29. Cohen SM, Saulenas AM, Sullivan CR, Albert DM. Further studies on the effect of vitamin D on RB. Arch Ophthalmol. 1988;106:541-543.
30. Kerr JFR, Wylli AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. J Cell Biol. 1972;26:239-257.
31. Nickells RW, Zack DJ. Apoptosis in ocular disease: A molecular overview. Ophthalmic Genetics. 1996;17:145-165.
32. O'Brien JM. Alternative treatment in RB. Ophthalmology. 1998;105:571-572.
33. 3 in rats and monkeys. Endocrinology. 1995;136:4749-4753.
34. 2 made in the human hepatoma, HEP3B. Biochem J. 1995;310:233-241.
35. Walters M. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992;13:719-764.
36. Brenner RV, Shabahang M, Schumacker LM, Nauta RJ, Uskokovic MR, Evans SR, Buras RR. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells. Cancer Lett. 1995;92:77-82.
37. Schwartz GG, Oeler TA, Uskokovic MR, Bahnson RR. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs. Anticancer Res. 1994;14:1077-1082.
38. 3 analogs: Effect on leukemic clonal growth, differentiation, and serum calcium. Leuk Res. 1995;19:65-72.
39. 3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps. Arch Biochem Biophys. 1992;29:181-186.
40. 3 on the proliferation of pancreatic cancer cell lines. Gastroenterology. 1996;110:1605-1613.
41. 3 is independent of nuclear receptor binding. J Biol Chem. 1995;270:15.962-15.965.
42. Brown AJ, Dusso A, Slatopolsky E. Selective vitamin D analogs and their therapeutic applications. Semin Nephrol. 1974;14:156-174.
43. Frey MR, Zhao X, Evans SS, Black JD. Activation of protein kinase C (PKC) isozymes inhibits cell cycle progression, modulates phosphorylation of the RBs (Rb) protein, and induces expression of p21waf1/cip1 in intestinal epithelial cells. Proc Am Assoc Cancer Res. 1996;37:51.
44. 3 analogue in rat colonic tumorigenesis. Gastroenterology. 1996;111:118-126.
45. Millard SS, Koff A. Cyclin-dependent kinase inhibitors in restriction point control, genomic stability, and tumorigenesis. J Cell Biochem. 1998;30/31:37-42.
46. Brugarolas JCC, Gordon JI, Beach D, Jacks T, Hannon CJ. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 1995;377:552-557.
47. Kondo Y, Kondo S, Liu JB, Haqqi T, Barnett GH, Barna BP. Involvement of p53 and waf1/cip1 in gamma-irradiation-induced apoptosis of retinoblastoma cells. Exp Cell Res. 1997;251:51-56.
48. 3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Cancer Res. 1996;56:3570-3576.
49. Vandewalle B, Hornez L, Wattez N, Revillion F, Lefebvre J. Vitamin-D3 derivatives and breast-tumor cell growth: Effect on intracellular calcium and apoptosis. Int J Cancer. 1995;61:806-811.
50. 3 stimulates apoptosis in CaCo-2 cells. Gastroenterology. 1997;112:A608.